0000899243-20-034578.txt : 20201218 0000899243-20-034578.hdr.sgml : 20201218 20201218213001 ACCESSION NUMBER: 0000899243-20-034578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AGUIAR ERIC CENTRAL INDEX KEY: 0001262325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 201402185 MAIL ADDRESS: STREET 1: 888 7TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-16 0 0001501134 Invitae Corp NVTA 0001262325 AGUIAR ERIC C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 1 0 0 0 Common Stock 2020-12-16 4 M 0 10000 24.16 A 10000 D Common Stock 2020-12-16 4 S 0 6400 50.738 D 3600 D Common Stock 2020-12-16 4 S 0 3600 51.4667 D 0 D Stock Option (right to buy) 24.16 2020-05-02 4 M 0 10000 0.00 D 2029-05-02 Common Stock 10000 0 D The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 7, 2020. Represents a weighted average sale price. Actual sale prices ranged from $50.30 to $51.29 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents a weighted average sale price. Actual sale prices ranged from $51.33 to $51.81 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. The option was fully vested on May 2, 2020. /s/ Thomas Brida, Attorney-in-Fact 2020-12-18